Substance / Medication

Urapidil

Overview

Active Ingredient
urapidil
RxNorm CUI
39230

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
[Effect of urapidil combined with phentolamine on hypertension during extracorporeal circulation].
Wang Fangjun, Chen Bin, Liu Yang et al. · Nan Fang Yi Ke Da Xue Xue Bao · 2014
PMID: 25263372RCT
Therapeutic effect of urapidil on myocardial perfusion in patients with ST-elevation acute coronary syndrome.
Yao Dao-kuo, Jia San-qing, Wang Lei et al. · Eur J Intern Med · 2009
PMID: 19327603RCT
Differential effects of urapidil and doxazosin on heart rate.
Stoschitzky Kurt, Stoschitzky Gergana, Wonisch Manfred et al. · Eur J Clin Pharmacol · 2007
PMID: 17225141RCT
Comparative efficacy and safety of urapidil and nitroglycerin for blood pressure control in acute cardiogenic pulmonary edema.
Yakin Furkan, Unal Emir, Altun Mustafa et al. · Am J Emerg Med · 2026
PMID: 41167008Observational
Oxygenation Effects of Antihypertensive Agents in Intensive Care: A Prospective Comparative Study of Nicardipine and Urapidil.
Suard Florimond, Mombrun Martin, Fischer Marc-Olivier et al. · Clin Pharmacol Ther · 2025
PMID: 39604146Observational
Short-acting urapidil compared to long-acting phenoxybenzamine in the management of pheochromocytoma.
Feld A, Mintziras I, Wächter S et al. · Langenbecks Arch Surg · 2025
PMID: 39934496ObservationalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Urapidil (substance)
SNOMED CT
698807007
UMLS CUI
C0077857
RxNorm CUI
39230

Clinical Data

This intervention maps to 2 entities in the Ltrl knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.